SI
Sofinnova Investments’s BioCryst Pharmaceuticals BCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-1,510,473
| Closed | -$20.9M | – | 60 |
|
|
2021
Q4 | $20.9M | Buy |
+1,510,473
| New | +$20.9M | 1.22% | 20 |
|
|
2021
Q3 | – | Sell |
-158,609
| Closed | -$2.51M | – | 66 |
|
|
2021
Q2 | $2.51M | Sell |
158,609
-220,165
| -58% | -$3.48M | 0.14% | 56 |
|
|
2021
Q1 | $3.85M | Sell |
378,774
-744,026
| -66% | -$7.57M | 0.23% | 52 |
|
|
2020
Q4 | $8.37M | Buy |
1,122,800
+329,746
| +42% | +$2.46M | 0.5% | 37 |
|
|
2020
Q3 | $2.73M | Sell |
793,054
-564,794
| -42% | -$1.94M | 0.2% | 50 |
|
|
2020
Q2 | $6.47M | Buy |
1,357,848
+542,158
| +66% | +$2.58M | 0.41% | 40 |
|
|
2020
Q1 | $1.63M | Sell |
815,690
-1,335,474
| -62% | -$2.67M | 0.15% | 50 |
|
|
2019
Q4 | $7.42M | Buy |
2,151,164
+1,634,430
| +316% | +$5.64M | 0.53% | 36 |
|
|
2019
Q3 | $1.48M | Buy |
516,734
+90,334
| +21% | +$259K | 0.13% | 60 |
|
|
2019
Q2 | $1.62M | Buy |
+426,400
| New | +$1.62M | 0.15% | 56 |
|